Douglas Elliman Inc.
Douglas Elliman Inc. (DOUG) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Douglas Elliman Inc. (DOUG), covering cash flow, earnings, and balance sheets.
Douglas Elliman Inc. (DOUG) Income Statement & Financial Overview
Explore comprehensive income reports for Douglas Elliman Inc. DOUG, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $253.40M | $243.32M | $266.32M | $285.75M |
| Cost of Revenue | $186.53M | $179.21M | $210.48M | $216.46M |
| Gross Profit | $66.88M | $47.50M | $55.84M | $69.29M |
| Gross Profit Ratio | $0.26 | $0.20 | $0.21 | $0.24 |
| R&D Expenses | $0.00 | $5.84M | $0.00 | $0.00 |
| SG&A Expenses | $47.06M | $57.16M | $47.90M | $47.008M |
| Operating Expenses | $72.23M | $63.001M | $47.90M | $72.97M |
| Total Costs & Expenses | $258.75M | $259.58M | $273.75M | $289.42M |
| Interest Income | $1.36M | $1.54M | $1.55M | $1.05M |
| Interest Expense | $1.53M | $1.46M | $1.46M | $0.00 |
| Depreciation & Amortization | $1.90M | $1.93M | $1.90M | $1.93M |
| EBITDA | $190.51M | -$2.95M | -$25.68M | -$1.15M |
| EBITDA Ratio | $0.75 | -$0.01 | -$0.10 | -$0.004 |
| Operating Income | -$5.35M | -$16.26M | $7.94M | -$3.67M |
| Operating Income Ratio | -$0.02 | -$0.07 | $0.03 | -$0.01 |
| Other Income/Expenses (Net) | -$194.90M | $9.92M | -$35.39M | $2.07M |
| Income Before Tax | -$6.28M | -$6.34M | -$27.45M | -$1.61M |
| Income Before Tax Ratio | -$0.02 | -$0.03 | -$0.10 | -$0.006 |
| Income Tax Expense | -$6.28M | -$251000.00 | $0.00 | $173000.00 |
| Net Income | -$6.28M | -$6.00M | -$27.18M | -$1.66M |
| Net Income Ratio | -$0.02 | -$0.02 | -$0.10 | -$0.006 |
| EPS | -$0.07 | -$0.07 | -$0.33 | -$0.02 |
| Diluted EPS | -$0.07 | -$0.07 | -$0.33 | -$0.02 |
| Weighted Avg Shares Outstanding | $84.37M | $85.67M | $82.36M | $83.20M |
| Weighted Avg Shares Outstanding (Diluted) | $84.37M | $85.67M | $82.36M | $83.34M |
Financial performance has remained strong, with revenue growing from $285.75M in Q2 2024 to $253.40M in Q1 2025. Gross profit continued to perform well, with margins at 26% in the latest quarter. Operating income reached -$5.35M in Q1 2025, holding a steady -2% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $190.51M. Net income dropped to -$6.28M, keeping EPS at -$0.07. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan